In Singapore, a clinical study called ISMOS has been launched by Haleon and A*STAR to examine whether multivitamin supplementation can support the metabolic health of midlife Asian women — a population long overlooked by global nutrition research. The initiative arrives at a moment when aging demographics across Asia are making metabolic syndrome an increasingly urgent concern, and when the science of women's health is slowly reckoning with the gaps left by decades of underrepresentation. At its heart, this study is an act of recognition: that evidence must be built for the people it is meant